Consumer News Popular Weight Loss Drugs Could Lower The Risk Of Certain Cancers, Study Finds
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Consumer News Popular Weight Loss Drugs Could Lower The Risk Of Certain Cancers, Study Finds is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
New weight loss drug, taken once weekly, leads to 20% weight loss in trial
Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, targets a different hormone called amylin, lost as much as 20% weight. Read More
Popular weight-loss drugs could take the edge off your alcohol buzz, study finds
Popular drugs credited with shrinking waistlines and controlling blood sugar may also take the edge off alcohol’s buzz, according to a new study. Researchers at Virginia Tech's Fralin Biomedical ... Read More
Eli Lilly weight-loss drug appears to suppress binge-eating signal, small study finds
Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 weight-loss drug appeared to temporarily suppress food-craving signals in the ... Read More
Popular weight-loss drugs show added heart protection for diabetes patients
Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical University of Munich (TUM) and Harvard Medical School ... Read More
Are Weight Loss Drugs About to Get Less Expensive?
That said, GLP-1 medications for weight loss are not for everyone, and they can cause unpleasant, even serious, side effects, including gastrointestinal issues like nausea and diarrhea, and ... Read More
A New Study Found That Weight-Loss Drugs Like Ozempic Could Lower Your Heart Attack Risk
A new University College London study featuring 17,604 participants age 45 and up discovered that semaglutide -- a GLP-1 agonist found in weight-loss drugs like Ozempic and Wegovy -- decreases the ... Read More
GLP-1 Weight Loss Drugs Tied to Lower Risk of Early Macular Degeneration
Preliminary studies suggest GLP-1s may offer long-term vision protection for people without diabetes, but researchers caution more research is still needed. During a 10-year study, people without ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus